Tasigna Atherosclerosis

Tasigna is one of the most popular cancer drugs in the world, with almost $2 billion in sales in 2016 alone. Prescribed to treat chronic myeloid leukemia, Tasigna has been found to cause a severe and rapid-onset atherosclerosis, a form of cardiovascular disease that a thickening of arterial walls. Atherosclerosis results in a reduced blood flow as the arterial walls narrow from a build-up of fibrofatty plaque and white blood cells. The lack of adequate blood circulation, primarily in the legs, can result in infections, tissue death, sometimes requiring amputation. Atherosclerosis caused by Tasgina may also lead to coronary artery disease, stroke and death. READ MORE

Tasigna Maker Fined $390 Million

Tasigna is produced and sold by Novartis AG Pharmaceutical, a Swiss Big Pharma company with over $50 billion in annual sales. In 2015 the United States Department of Justice charged Novartis with $3.35 billion in overcharges and fines resulting from Novartis' use of illegal kickbacks to boost drug sales and submitting false claims to healthcare programs. The Department of Justice settled the case with Novartis for $390 million. South Korea recently levied fine against Novartis for using illegal practices to boost drug sales in that country. Novartis paid the US Department of Justice $422 million in 2010 for illegally marketing pharmaceutical products. READ MORE

Tasigna Lawsuits

Tasigna Lawsuits for persons, or the family members, who used Tasigna and were then diagnosed with atherosclerosis, peripheral arterial disease, coronary artery disease, stroke, amputation or death, are because Novartis was not only aware of the increased risk of atherosclerosis from Tasigna usage, but that the company hid that information from American Tasigna users. Our Tasigna lawsuits will demonstrate that Novartis was aware of the Tasigna atherosclerosis link from medical research published in 2011 and issued a Tasigna atherosclerosis warning through Health Canada in the spring of 2013. READ MORE

The Onder Law Firm

The Onder Law Firm handles serious and complex litigation, such as Tasigna lawsuits, across the country against multinational conglomerates. Its mission is the pursuit of justice, no matter how difficult the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. The Onder Law Firm is a recognized leader in multi-district litigation such as products liability and failure to warn cases. READ MORE

Free Tasigna Lawyer Consultation


Tasigna Lawyer | Free Attorney Consultation for Tasigna Lawsuits

National Tasigna Lawyers Provide Information About Tasigna Atherosclerosis Claims

Tasigna Lawyer ConsultationTasigna (nilotinib) is one of the ten most popular cancer treatment drugs in the world, used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+CML). Medical research has shown that Tasigna usage leads to the disease Atherosclerosis, the narrowing and hardening of the arties due to build-up of plaque and white blood cells. A 2011 medical report showed that 25% of Tasigna users suggered from vascular problems and 16% of Tasigna users suffered from Peripheral Arterial Disease.

Onder Law's Tasigna Lawyers are handling cases against the maker of Tasigna not because Tasigna caused atherosclerosis, but because the drug's maker knew that it could cause atherosclerosis and lead to even graver health complications, such as amputation of the legs, and then not only chose to not disclose that risk to American Tasigna users, but then engaged in illegal activity so that more Americans would use Tasigna.

What Are the Dangers of Atherosclerosis?

Death, heart attack, stroke, coronary artery disease, peripheral arterial disease, potentially leading to amputation of one or more limbs. Tasigna atherosclerosis has been found to both occur rapidly and severely.

Why Should I Consult with a Tasigna Lawyer?

Money can't suddenly reverse atherosclerosis, a heart attack or stroke, and certainly can't bring back a relative. It can pay for medical expenses and, unfortunately, is often the only way to ssend drug companies a message to stop putting profits before patients.

Tasigna Maker Has History of Illegal Activity

Tasigna is made and marketed by Novartis AG Pharmaceutical. Based in Switzerland, Novartis is one of the multi-national corporations that make up Big Pharma. The company did just over $50 billion in total sales in 2015, and its corporate history shows that Novartis has been willing to overstep the law in order to increase sales. Since 2010, Novartis has paid the US Department of Justice over $800 million tosettle both criminal and civil charges. Furthermore, Novartis has paid similar fines in other countries as a result of illegal pharmaceutical marketing.

2015: Novartis Pays $390 Million in Fines Relating to Tasigna

The United States Department of Justice charged Novartis with paying specialty pharmacies illegal kickbacks to get them to recommend Novartis drugs to persons using Medicaid and Medicare to fill prescriptions for six different Novartis drugs, including Tasigna. Four years after Novartis was fully aware of the Tasigna atherosclerosis risk, after it had changed the Tasigna product packaging to warn Canadian Tasigna users of atherosclerosis, Novartis was so intent on earning hundreds of millions of dollars more from Tasigna that it engaged in illegal activity. The federal lawsuit against Novartis included Tasigna and five other drugs.

No Fees Unless We Collect for You - Contingency Representation for Tasigna Atherosclerosis Claims

The Onder Law Firm will represent all persons involved in a Tasigna lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form or call us at 1-877-ONDER-LAW and one of our attorneys handling Tasigna lawsuits will contact you to answer any of your questions.

The Onder Law Firm is a St. Louis based law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder Law has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation, such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $1.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won $197 million in three talcum powder ovarian cancer lawsuits in St. Louis in 2016 and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.onderlaw.com or call 1-877-ONDER-LAW.


Onder Law Has Been Covered By:

Onder Law on ABC News Onder Law on the New York Times Onder Law on USA Today Onder Law on Chicago Tribune Onder Law on LA Times Onder Law on Nightline

Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards